GSK plc
Search results
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide.
Our company. We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
At AstraZeneca we’re united by our desire to push the boundaries of science to deliver life-changing medicines. We know it’s how we will continue to transform the lives of millions of patients around the world while delivering value to our employees, our communities, and the environment.
To tackle some of the world’s greatest healthcare challenges, we’ve created an inspiring working environment with world-class talent and opportunities. In India, we merge our brightest minds and cutting-edge resources to make a real difference to lives the world over. Search jobs.
Life at AstraZeneca. We’re curious about science and the advancement of knowledge. We find creative ways to approach new challenges. We’re driven to make the right choices and be accountable for our actions. As an organisation centred around what makes us human, we put a big focus on people.
AstraZeneca | 2,923,451 followers on LinkedIn. What science can do | We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the...
The AstraZeneca vaccine has an efficacy of 72% against symptomatic SARS-CoV-2 infection, as shown by the primary analysis of data irrespective of interdose interval from trial participants who received 2 standard doses with an interval varying from about 4 to 12 weeks.
Mar 25, 2021 · AstraZeneca has updated the efficacy result of its coronavirus vaccine trial in the US, after health officials insisted they wanted to include the latest information.
Apr 6, 2022 · AstraZeneca’s Global Technology Centre in India increases its focus on driving innovation – repositioning itself as a Global Innovation and Technology Centre. PUBLISHED 6 April 2022. Chennai, April 6, 2022: AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of AstraZeneca announced today that they have ...
